NCT00003877View on ClinicalTrials.gov

Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 1998

Primary Completion Date

February 29, 2000

Study Completion Date

December 31, 2000

Conditions
Breast Cancer
Interventions
BIOLOGICAL

filgrastim

DRUG

carboplatin

DRUG

cyclophosphamide

DRUG

paclitaxel

DRUG

thiotepa

PROCEDURE

in vitro-treated bone marrow transplantation

PROCEDURE

in vitro-treated peripheral blood stem cell transplantation

Trial Locations (3)

48201

Barbara Ann Karmanos Cancer Institute, Detroit

14263-0001

Roswell Park Cancer Institute, Buffalo

44106-5065

Ireland Cancer Center, Cleveland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Roswell Park Cancer Institute

OTHER

NCT00003877 - Peripheral Stem Cell Transplantation With or Without Stromagen Following Chemotherapy in Treating Women With Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter